Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone added to lidocaine for inferior alveolar nerve block in symptomatic irreversible pulpitis
IRCT20091004002541N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irreversible pulpitis comparing Lidocaine + epinephrine + dexamethasone with Lidocaine + epinephrine + sterile distilled water control (2 arms). Primary endpoint: Pain. Started Aug 2016; status: completed.
02
Drugs
dexamethasonelidocaineepinephrine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20091004002541N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091004002541N7.